Insiders stepping in to names hurt by recent AI fears ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏
Tuesday, February 17, 2026
|
|
|
Every day, we sift through the filings to spot where the real conviction lies – cutting through the noise to highlight the most meaningful insider moves. 📌 Nasdaq $NDAQ — Investor AB purchased $15.84 Million per Form 4.
Strategic Nordic holding company increasing exposure to the global exchange operator after a steep 25% decline over a two week period. 📌 C.H. Robinson $CHRW — President & Chief Executive Officer, Chief Financial Officer, and multiple directors bought $501,637 per Form 4.
Broad executive participation within a global logistics operator that got shocked last week due to AI disruption fears. Here's The Hot Corner, with data from February 13, 2026: |
Click the table to enlarge it. |
📌 Personalis $PSNL — Tempus AI acquired $2.74 Million per Form 4.
Corporate buyer stepping into a genomics and diagnostics name carving out a textbook reversal base. 📌 Zenas BioPharma $ZBIO — Multiple directors bought $1.08 Million per Form 4.
More buying at the board level in a biotech climbing back up after a sharp decline. Buyers remain strong. If you want this actionable trade ideas based on insider trading, join Hot Corner Insider risk-free. |
|
|
Alfonso De Pablos | Director of Research, All Star Charts |
|
|
Stock Market Media emails are a financial publication of general circulation and only offers impersonal advice, not tailored to individual needs of a specific client or group. Any comments or statements made herein do not necessarily reflect those of Stock Market Media LLC or its affiliates (collectively, "Stock Market Media") and do not constitute buy or sell recommendations. Unless specifically indicated, this message is not an official confirmation of any transaction. The contents of any email communications to or from Stock Market Media may be monitored or reviewed at Stock Market Media's discretion. Stock Market Media accepts no responsibility for any loss or damage arising in any way from the use of this transmission and any attachments; it is the responsibility of the recipient to ensure that they are virus free. If you reply to this email, please note that we are a public investor and do not want any material non-public information. We do not agree to keep confidential any information you provide and do not agree to any restrictions on our trading activity, except pursuant to a written confidentiality agreement executed by Stock Market Media. |
Want to change how you receive these emails? You can manage your preferences here unsubscribe. © 2026 Stock Market Media 624 Broadway, Suite 405 San Diego, CA 92101 |
|
|
|